Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1992 1
2008 1
2010 1
2014 1
2015 1
2017 2
2018 2
2019 2
2020 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ, Pineda L, Berglind A, Tummala R; TULIP-2 Trial Investigators. Morand EF, et al. N Engl J Med. 2020 Jan 16;382(3):211-221. doi: 10.1056/NEJMoa1912196. Epub 2019 Dec 18. N Engl J Med. 2020. PMID: 31851795 Clinical Trial.
Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis.
Loza E, Lajas C, Andreu JL, Balsa A, González-Álvaro I, Illera O, Jover JÁ, Mateo I, Orte J, Rivera J, Rodríguez Heredia JM, Romero F, Martínez-López JA, Ortiz AM, Toledano E, Villaverde V, Carmona L, Castañeda S. Loza E, et al. Among authors: rodriguez heredia jm. Rheumatol Int. 2015 Mar;35(3):445-58. doi: 10.1007/s00296-014-3196-7. Epub 2014 Dec 28. Rheumatol Int. 2015. PMID: 25543267 Review.
Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence.
Muñoz-Fernández S, Otón-Sánchez T, Carmona L, Calvo-Alén J, Escudero A, Narváez J, Rodríguez Heredia JM, Romero Yuste S, Vela P, Luján Valdés S, Royo García A, Baquero JL. Muñoz-Fernández S, et al. Among authors: rodriguez heredia jm. Rheumatol Int. 2018 Dec;38(12):2289-2296. doi: 10.1007/s00296-018-4152-8. Epub 2018 Sep 24. Rheumatol Int. 2018. PMID: 30251128
Influence of prognosis factors on the prescription of targeted treatments in rheumatoid arthritis: A Delphi survey.
Narváez J, Otón T, Calvo-Alén J, Escudero-Contreras A, Muñoz-Fernández S, Rodríguez-Heredia JM, Romero-Yuste S, Vela-Casasempere P, Luján S, Baquero JL, Carmona L. Narváez J, et al. Among authors: rodriguez heredia jm. Joint Bone Spine. 2021 Jul;88(4):105172. doi: 10.1016/j.jbspin.2021.105172. Epub 2021 Mar 6. Joint Bone Spine. 2021. PMID: 33689842 Free article.
Disease activity indexes might not capture the same disease aspects in males and females with ankylosing spondylitis: A real-world nationwide analysis.
Fernández-Carballido C, Jovaní V, Catalán EB, Moreno-Ramos MJ, Sanz Sanz J, Gallego A, García Vivar ML, Rodríguez-Heredia JM, Sanabra C, Sastré C. Fernández-Carballido C, et al. Among authors: rodriguez heredia jm. Front Med (Lausanne). 2022 Dec 21;9:1078325. doi: 10.3389/fmed.2022.1078325. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36619648 Free PMC article.
Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry.
Boteanu A, Leon L, Pérez Esteban S, Rabadán Rubio E, Pavía Pascual M, Bonilla G, Bonilla González-Laganá C, García Fernandez A, Recuero Diaz S, Ruiz Gutierrez L, Sanmartín Martínez JJ, de la Torre-Rubio N, Nuño L, Sánchez Pernaute O, Del Bosque I, Lojo Oliveira L, Rodríguez Heredia JM, Clemente D, Abasolo L, Bachiller-Corral J. Boteanu A, et al. Among authors: rodriguez heredia jm. Mod Rheumatol. 2023 Dec 22;34(1):97-105. doi: 10.1093/mr/roac148. Mod Rheumatol. 2023. PMID: 36516217
Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study.
Alegre-Sancho JJ, Juanola X, Rodríguez-Heredia JM, Manero J, Villa-Blanco I, Laiz A, Arteaga MJ, Cea-Calvo L, González CM. Alegre-Sancho JJ, et al. Among authors: rodriguez heredia jm. Medicine (Baltimore). 2021 Apr 2;100(13):e25223. doi: 10.1097/MD.0000000000025223. Medicine (Baltimore). 2021. PMID: 33787605 Free PMC article.
Biologic Disease-modifying antirheumatic drug attributes in the first lines of treatment of rheumatoid arthritis. 2015 ACORDAR project.
Muñoz-Fernández S, Bustabad Reyes MS, Calvo Alén J, Castaño Sánchez M, Chamizo Carmona E, Corominas H, Fernández-Llanio Comella N, Hidalgo Calleja MC, Pérez Venegas JJ, Rodríguez Heredia JM, Romero Yuste SM, Ruiz-Esquide Torino V; Grupo de trabajo ACORDAR 2015. Muñoz-Fernández S, et al. Among authors: rodriguez heredia jm. Reumatol Clin (Engl Ed). 2018 Mar-Apr;14(2):90-96. doi: 10.1016/j.reuma.2016.10.001. Epub 2017 Jan 3. Reumatol Clin (Engl Ed). 2018. PMID: 28065486 Free article. English, Spanish.
Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada.
Weijers L, Baerwald C, Mennini FS, Rodríguez-Heredia JM, Bergman MJ, Choquette D, Herrmann KH, Attinà G, Nappi C, Merino SJ, Patel C, Mtibaa M, Foo J. Weijers L, et al. Among authors: rodriguez heredia jm. Rheumatol Int. 2017 Jul;37(7):1111-1123. doi: 10.1007/s00296-017-3739-9. Epub 2017 May 30. Rheumatol Int. 2017. PMID: 28560470 Free PMC article. Clinical Trial.
15 results